Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

healthcare value value-based care money dollar

FDA approves world’s most expensive drug, a hemophilia B treatment expected to cost $3.5M

The single-dose gene therapy can help patients reduce their risk of bleeding events and discontinue factor IX prophylaxis therapy.

ADHD medications and CVD: Lessons learned from a new meta-analysis of nearly 4 million patients

The new study, published in JAMA Network Open, should help ease any concerns patients may have about regularly taking ADHD medications. 

Thumbnail

Use of NSAIDs 'should be revisited' after study reveals they may worsen arthritis

The use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are seeking when it comes to joint pain, according to new findings to be presented at RSNA 2022. 

By visualizing metabolism, researchers hope to improve heart disease diagnosis

Hyperpolarized MRI may help identify metabolism problems—which can be an early signal of a heart condition—in real time.

Thumbnail

The power of AI: Advanced algorithm IDs heart issues using Apple Watch data

A team of Mayo Clinic specialists led the analysis, sharing their findings in Nature Medicine.

Early catheter ablation superior to medication when treating ventricular tachycardia storm

VT storm is associated with a heightened risk of death or significant complications. Early catheter ablation, it seems, is the most effective treatment option for this potentially fatal condition. 

Thumbnail

FDG PET/CT spots COVID-induced pancreatitis

There are limited data to determine whether pancreatitis in COVID patients is the result of a stress response triggered by severe illness or by direct damage to the β-cell structure and function.

Abiomed’s Impella RP Flex with SmartAssist heart pump has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of acute right heart failure for up to 14 days.

Surgeons make history, become first in world to implant Abiomed’s new heart pump for right heart failure

Two specialists with Hackensack University Medical Center in New Jersey performed the procedure. The patient, a 71-year-old woman, is doing well.